Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Apr 30, 2025 | (FY)Apr 30, 2024 | (Q4)Apr 30, 2024 | (Q3)Jan 31, 2024 | (Q2)Oct 31, 2023 | (Q1)Jul 31, 2023 | (FY)Apr 30, 2023 | (Q4)Apr 30, 2023 | (Q3)Jan 31, 2023 | (Q2)Oct 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 9.15%46.48B | 7.35%42.58B | 13.40%8.74B | 7.56%17.27B | 5.22%9.66B | 2.82%6.92B | 1.58%39.67B | -6.71%7.71B | 0.04%16.05B | 4.77%9.18B |
| Cost of revenue | 11.34%34.98B | 5.93%31.42B | 17.16%7.02B | 3.64%12.56B | 2.13%6.87B | 3.04%4.96B | 3.59%29.66B | -4.53%5.99B | 4.21%12.12B | 6.25%6.73B |
| Gross profit | 3.01%11.5B | 11.55%11.16B | 0.27%1.72B | 19.65%4.7B | 13.69%2.78B | 2.27%1.96B | -3.96%10.01B | -13.58%1.71B | -10.97%3.93B | 0.93%2.45B |
| Operating expense | 3.47%8.8B | 9.66%8.5B | 33.61%2.29B | 3.44%2.46B | -1.23%1.99B | 6.98%1.77B | 0.43%7.76B | -18.13%1.72B | 5.83%2.37B | 8.20%2.01B |
| Operating profit | 1.53%2.7B | 18.03%2.66B | -19,119.71%-575.44M | 44.37%2.25B | 83.00%793.56M | -27.14%192.88M | -16.54%2.25B | 97.37%-2.99M | -28.32%1.56B | -23.09%433.64M |
| Net non-operating interest income (expenses) | -37.40%-94.06M | -69.27%-68.45M | -2.07%-12.77M | -93.54%-20.06M | -117.41%-19.35M | -87.86%-16.27M | -19.04%-40.44M | -74.28%-12.52M | -0.28%-10.36M | 6.35%-8.9M |
| Non-operating interest income | 391.67%59K | -55.56%12K | -75.00%4K | --0 | -27.27%8K | --0 | 68.75%27K | 60.00%16K | --0 | --11K |
| Non-operating interest expense | 37.46%94.12M | 69.19%68.47M | 1.97%12.78M | 93.54%20.06M | 117.23%19.36M | 87.86%16.27M | 19.07%40.47M | 74.26%12.53M | 0.28%10.36M | -6.29%8.91M |
| Net investment income | 9.87%62.25M | 36.58%56.66M | 0.00%15K | 25.21%25.51M | 0.02%6.2M | 67.41%24.93M | 108.23%41.48M | 0.00%15K | 191.67%20.37M | 19.93%6.2M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -34.59M | 0 | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -127.08%-9.62M | -41.34%35.5M | -79.47%14.47M | -16.21%-9.73M | 143.84%694K | 30.07M | 150.16%60.52M | 162.95%70.48M | -8.37M | -2,335.38%-1.58M |
| Less:Other special charges | 87.27%-4.52M | 41.34%-35.5M | 79.47%-14.47M | 16.21%9.73M | ---694K | ---30.07M | -150.16%-60.52M | -162.95%-70.48M | --8.37M | ---- |
| Less:Write off | --14.13M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | -23.58%278.8M | 0.89%364.85M | -29.40%60.4M | 68.69%119.62M | -22.24%88.24M | 5.33%96.6M | 23.74%361.64M | 87.51%85.54M | 5.78%70.91M | 8.37%113.48M |
| Income before tax | -4.76%2.9B | 13.88%3.05B | -465.30%-513.34M | 45.02%2.36B | 60.15%869.35M | -9.50%328.21M | -6.32%2.67B | 174.96%140.53M | -27.12%1.63B | -18.27%542.84M |
| Income tax | 26.88%950.73M | -9.98%749.31M | -747.13%-364.72M | 44.27%751.31M | 47.30%262.36M | 30.05%100.36M | -9.13%832.43M | 245.54%56.36M | -26.22%520.79M | -13.56%178.11M |
| Net income | -15.09%1.95B | 24.67%2.3B | -276.57%-148.61M | 45.38%1.61B | 66.43%606.99M | -20.19%227.84M | -5.00%1.84B | 156.58%84.17M | -27.54%1.11B | -20.38%364.72M |
| Net income continuous operations | -15.09%1.95B | 24.67%2.3B | -276.57%-148.61M | 45.38%1.61B | 66.43%606.99M | -20.19%227.84M | -5.00%1.84B | 156.58%84.17M | -27.54%1.11B | -20.38%364.72M |
| Noncontrolling interests | 0 | 0 | 0 | |||||||
| Net income attributable to the company | -15.09%1.95B | 24.67%2.3B | -276.57%-148.61M | 45.38%1.61B | 66.43%606.99M | -20.19%227.84M | -5.00%1.84B | 156.58%84.17M | -27.54%1.11B | -20.38%364.72M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -15.09%1.95B | 24.67%2.3B | -276.57%-148.61M | 45.38%1.61B | 66.43%606.99M | -20.19%227.84M | -5.00%1.84B | 156.58%84.17M | -27.54%1.11B | -20.38%364.72M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -15.09%386.52 | 24.67%455.21 | -276.51%-29.46 | 45.37%319.15 | 66.44%120.35 | -20.19%45.17 | -5.00%365.14 | 156.60%16.69 | -27.53%219.54 | -20.38%72.31 |
| Diluted earnings per share | -15.09%386.52 | 24.67%455.21 | -276.57%-29.4652 | 45.38%319.15 | 66.43%120.3449 | -20.19%45.17 | -5.00%365.14 | 156.58%16.6871 | -27.53%219.5333 | -20.38%72.31 |
| Dividend per share | 8.33%65 | 9.09%60 | 9.09%60 | 0 | 0 | 0 | 10.00%55 | 10.00%55 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |